Stryker completed the acquisition of Inari Medical for $4.9bn.

Stryker, a medical technologies company, completed the acquisition Inari Medical, a medical device company, for $4.9bn. “The acquisition of Inari Medical marks a significant milestone in expanding our interventional endovascular portfolio. We look forward to welcoming the talented Inari team to Stryker and working together to improve outcomes for patients worldwide," Kevin Lobo, Stryker Chair and Chief Executive Officer.